![](/img/cover-not-exists.png)
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro)
von Minckwitz, G., Rezai, M., Fasching, P. A., Huober, J., Tesch, H., Bauerfeind, I., Hilfrich, J., Eidtmann, H., Gerber, B., Hanusch, C., Blohmer, J. U., Costa, S. D., Jackisch, C., Paepke, S., SchneVolume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt410
Date:
January, 2014
File:
PDF, 426 KB
english, 2014